ArticleAnalytical and bioanalytical chemistry2026
Rapid derivatisation of novichok precursor amidines for improved detection by GC-MS.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, the Annex on Chemicals of the Chemical Weapons Convention was amended to include four new entries to the Schedule 1 toxic chemical list. These new entries included the novichok agents A-230, A-232 and A-234. In addition to this, 17 N,N-dialkyl(alkan)imidamides precursor chemicals were added to various export control lists. These additions increased the population of chemicals that could require reporting during both the Organisation for the Prohibition of Chemical Weapons (OPCW) Official Proficiency Test (PT) and authentic sample analysis. The network of OPCW Designated Laboratories (DL) therefore needs to be aware of these newly listed chemicals, their precursor chemicals and degradation products and associated chromatographic and mass spectral properties. N,N-Dialkyl(alkan)imidamides often exhibit poor gas chromatography properties and require derivatisation prior to analysis. Complicating this is the difficulty in silylating N,N-dialkyl(alkan)imidamides in aqueous environments, in addition to the inherent instability of the subsequent silyl ester. Therefore, derivatising agents that readily react with N,N-dialkyl(alkan)imidamides to form derivatives with improved GC-MS properties and are stable for extended time periods are of importance to DLs. A possibility to address these twin concerns is derivatising with an alkyl chloroformate using modified Schotten-Baumann conditions to form the corresponding carbamate. Using these conditions, a series of N,N-dialkyl(alkan)imidamides were derivatised with methyl chloroformate and assessed for an improvement to both their GC-MS behaviour and stability. Additionally, samples from the 56th and 57th OPCW Official PT, spiked with N,N-diisopropylethanimidamide and N-methyl-N-propylethanimidamide respectively, were treated with methyl chloroformate. Significant improvements in stability and chromatographic properties were observed in all instances.
Indexed as
Identifiers
41733617What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.